Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pharmacotherapy ; 31(3): 333, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21361743

RESUMO

Sepsis remains one of the leading causes of mortality during pregnancy. Because of the inherent limitations of conducting scientific investigations during pregnancy, a great deal of clinical decision making is based on observational reports, an understanding of the physiologic changes of pregnancy, and consideration for risk to the fetus. We describe a 20-year-old pregnant woman at 20 weeks' gestation who was admitted to an obstetric ward for dehydration and a urinary tract infection. Approximately 36 hours later, the patient's clinical status deteriorated, with the development of mental status changes, acute respiratory failure, and renal failure. Drotrecogin alfa (activated) was started, as the patient's Acute Physiology and Chronic Health Evaluation II score was 27 (> 25 is the typical score required for drotrecogin alfa [activated] therapy); within 48 hours the patient's clinical status dramatically improved. The patient completed 96 uninterrupted hours of therapy and was subsequently discharged after a 15-day hospitalization, with no apparent sequelae. Approximately 17 weeks later, the patient gave birth to a 3.42-kg female infant with no congenital abnormalities. To our knowledge, this represents the second case report to describe the use of drotrecogin alfa (activated) along with the status of the mother and fetus both after completion of therapy and after subsequent delivery. Because of the threat of mortality from sepsis during pregnancy, combined with the inherent limitations associated with clinical research during pregnancy, further reports and investigation into the treatment of sepsis in the pregnant patient are warranted.


Assuntos
Anti-Infecciosos/uso terapêutico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Proteína C/uso terapêutico , Sepse/tratamento farmacológico , APACHE , Feminino , Humanos , Lactente , Gravidez , Proteínas Recombinantes/uso terapêutico , Índice de Gravidade de Doença , Resultado do Tratamento , Adulto Jovem
2.
Am J Pharm Educ ; 74(6): 100, 2010 Aug 10.
Artigo em Inglês | MEDLINE | ID: mdl-21045942

RESUMO

OBJECTIVE: To create a self-sufficient, innovative method for providing cardiopulmonary resuscitation (CPR) education within a college of pharmacy using a student-driven committee, and disseminating CPR education into the community through a service learning experience. DESIGN: A CPR committee comprised of doctor of pharmacy (PharmD) students at the University of Tennessee College of Pharmacy provided CPR certification to all pharmacy students. The committee developed a service learning project by providing CPR training courses in the community. Participants in the course were required to complete an evaluation form at the conclusion of each training course. ASSESSMENT: The CPR committee successfully certified more than 1,950 PharmD students and 240 community members from 1996 to 2009. Evaluations completed by participants were favorable, with 99% of all respondents (n = 351) rating the training course as either "excellent" or "good" in each of the categories evaluated. CONCLUSION: A PharmD student-directed committee successfully provided CPR training to other students and community members as a service learning experience.


Assuntos
Reanimação Cardiopulmonar/educação , Educação em Farmácia , Estudantes de Farmácia , Certificação , Humanos , Faculdades de Farmácia , Tennessee
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA